-
Singapore’s war on Diabetes has a new ally
biospectrumasia
April 08, 2019
A cause as big as the War on Diabetes 6 needs every help it can get - a new ally joins the fight……
-
Singapore recalls 3 brands of Losartan medicines
biospectrumasia
April 04, 2019
Losartan is a medication used primarily to control high blood pressure.
-
Beximco Pharma enters EU market
biospectrumasia
November 16, 2018
Singapore: Beximco Pharmaceuticals, a manufacturer of generic pharmaceutical products and active pharmaceutical ingredients in Bangaldesh, has commenced export of its products to Europe
-
"Biomarkers can play a key role in improving diagnosis and disease management of heart failure. "
biospectrumasia
November 15, 2018
Recently, Priyanka Bajpai from BioSpectrum Asia spoke to Dr Antoni Bayes-Genis on the need to staying healthy and the future of NT-proBNP as a cardiac biomarker.
-
Singapore rides high on biomedical research
biospectrumasia
October 24, 2018
Singapore rides high on biomedical research
-
UK regulator declines Roche MS drug
biospectrumasia
October 15, 2018
The drug got EU marketing authorization in January, leaving it to member states to decide whether to provide the treatment
-
Cell Research Corporation announces new senior advisors
biospectrumasia
August 29, 2018
CellResearch identified the broad applicability of cord lining mesenchymal and epithelial stem cells as potential treatments for an extensive number of indications including Haemophilia A, myocardial infarction and Parkinson’s disease.
-
WuXi Biologics to build new facility in Singapore
biospectrumasia
May 28, 2018
The new manufacturing facility will be the company’s first overseas site in Asia and second site outside of China
-
Singapore researchers offer new hope for stem cells
biospectrumasia
May 22, 2018
The researchers found that a laboratory-synthesised substance called C7 is able to expand the number of blood-forming stem cells in the umbilical cord through cell culture.
-
Suven gets product patents by Australia, Singapore
financialexpress
May 21, 2018
Suven Life Sciences has been granted two product patents by Australia and one by Singapore corresponding to a new chemical entity (NCE) for treatment of disorders associated with neurodegenerative diseases.